Results for tag: "Palmoplantar Pustulosis Drug"

Palmoplantar Pustulosis (PPP) is a chronic skin disorder characterized by recurrent pustules on the palms and soles. It is a type of pustular psoriasis, and is often treated with topical corticosteroids, systemic retinoids, and phototherapy. Dermatological drugs are used to treat a variety of skin conditions, including PPP. These drugs are typically administered topically, and can include corticosteroids, retinoids, and immunomodulators. The Palmoplantar Pustulosis Drug market is a subset of the larger Dermatological Drugs market. It is composed of drugs specifically designed to treat PPP, and is expected to grow in the coming years due to increasing prevalence of the condition. Some companies in the Palmoplantar Pustulosis Drug market include AbbVie, Amgen, Celgene, Janssen, and Novartis. Show Less Read more